Tibet Pharmaceuticals, Inc.
OTC: TBET0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hong Yu
- Employees
- 190
- Headquarters
- Wanchai, Hong Kong SAR China
- IPO year
- 2023
- Market cap
- $1.5K
Loading TBET…
Loading profile data…Frequently asked questions about TBET
What does Tibet Pharmaceuticals, Inc. (TBET) do?
Tibet Pharmaceuticals, Inc. operates as a specialized pharmaceutical company, primarily focused on the research, development, manufacturing, marketing, and distribution of traditional Tibetan medicines. The company conducts its core activities through its operational subsidiary, Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (YSTP), whic...
Where does TBET trade?
Tibet Pharmaceuticals, Inc. (TBET) trades on the Other OTC.
What sector is TBET in?
Tibet Pharmaceuticals, Inc. (TBET) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tibet Pharmaceuticals, Inc.?
Hong Yu is the chief executive officer of Tibet Pharmaceuticals, Inc. (TBET).
Where is Tibet Pharmaceuticals, Inc. headquartered?
Tibet Pharmaceuticals, Inc. is headquartered in Hong Kong SAR China.
Does TBET pay a dividend?
Tibet Pharmaceuticals, Inc. (TBET) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TBET go public?
Tibet Pharmaceuticals, Inc. (TBET) completed its initial public offering in 2023.